key: cord-0821067-jxpf6y7h
authors: Hoxha, Elion
title: Erfahrungen aus dem deutschen COVID-19-Register
date: 2020-12-09
journal: Nephrologe
DOI: 10.1007/s11560-020-00468-w
sha: 9f830ff987f56f5c43c482623df3ecdd5e1b9b54
doc_id: 821067
cord_uid: jxpf6y7h

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections represent a particular risk for several groups of patients with nephrological diseases. Patients on dialysis represent a particularly vulnerable group during the SARS-CoV‑2 pandemic. Initial data from international registries show a much higher mortality of dialysis patients with SARS-CoV‑2 infections. Because of the substantial differences between the healthcare systems, (state) preventive measures and treatment possibilities etc., in the different countries worldwide, local and national registry data cannot be easily transferred. In order to gain a reliable overview of the prevalence and mortality of dialysis patients with SARS-CoV‑2 infection in Germany, the German Society of Nephrology implemented a national registry for dialysis patients with a SARS-CoV‑2 infection. Within this framework a standardized collection of these data is carried out on a weekly basis, which should enable a real-time overview of the case numbers and perhaps the acquisition of new scientific knowledge. Particularly in the current phase of the pandemic (autumn 2020), which is accompanied by a multiplication of the numbers of daily new-onset cases within only a few weeks, such data are highly relevant for the estimation and adjustment of the personnel, structural and organizational needs as well as the capacities for the treatment of patients.

Dialysepatienten haben ein erhöhtes Risiko sowohl für eine Infektion mit SARS-CoV-2 als auch für einen ungünstigen Verlauf der dadurch verursachten COVID-19("coronavirus disease 2019")-Erkrankung. Patienten 

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections represent a particular risk for several groups of patients with nephrological diseases. Patients on dialysis represent a particularly vulnerable group during the SARS-CoV-2 pandemic. Initial data from international registries show a much higher mortality of dialysis patients with SARS-CoV-2 infections. Because of the substantial differences between the healthcare systems, (state) preventive measures and treatment possibilities etc., in the different countries worldwide, local and national registry data cannot be easily transferred. In order to gain a reliable overview of the prevalence and mortality of dialysis patients with SARS-CoV-2 infection in Germany, the German Society of Nephrology implemented a national registry for dialysis patients with a SARS-CoV-2 infection. Within this framework a standardized collection of these data is carried out on a weekly basis, which should enable a real-time overview of the case numbers and perhaps the acquisition of new scientific knowledge. Particularly in the current phase of the pandemic (autumn 2020), which is accompanied by a multiplication of the numbers of daily newonset cases within only a few weeks, such data are highly relevant for the estimation and adjustment of the personnel, structural and organizational needs as well as the capacities for the treatment of patients.

Coronavirus · Dialysis · Registries · Prevalence · Mortality die Anzahl der erkrankten Patienten sowie Dynamik der Pandemie. Aus diesen Gründen sind Registerdaten nicht ohne Weiteres von einem Land auf das andere übertragbar.

Bereits im März 2020 wurde unter dem Schirm der Deutschen Gesellschaft für Nephrologie (DGf N) ein Register für Dialysepatienten mit einer SARS-CoV-2-Infektion entwickelt. Das Register wurde in 2 Stufen aufgebaut. In der ersten 

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Kidney disease is associated with in-hospital death of patients with COVID-19

MS Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

COVID-19 infection in ESKD: findings from a prospective diseasesurveillanceprogram at dialysis facilities in New York City and long island

A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection

SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience

COVID-19 in patients on maintenance dialysis in the Paris region

Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

COVID-19-associated nephritis: early warning for disease severity and complications?